中文名 |
醋酸去氧皮质酮 |
---|---|
英文名 |
21-(acetyloxy)-pregn-4-ene-3,20-dione |
中文别名 |
乙酸脱氧皮质甾酮 | 醋酸脱氧皮质酮 | 乙酸-11-脱氧皮质甾酮 | 21-乙酸羟基孕酮 |
英文别名 |
更多 |
描述 |
Deoxycorticosterone 醋酸盐是一种肾上腺皮质素, 作为前体醛固酮。 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
相关类别 |
|
||||||||||||
溶解度 |
体外:
DMSO:≥33mg / mL(88.59 mM) * “≥”表示可溶,但饱和度未知。
|
||||||||||||
储备液 |
|
||||||||||||
存储 |
|
||||||||||||
运输 |
室温;可能会有所不同 |
||||||||||||
SMILES |
C[C@@]12[C@@H](C(COC(C)=O)=O)CC[C@@]1([H])[C@]3([H])CCC4=CC(CC[C@]4(C)[C@@]3([H])CC2)=O |
||||||||||||
相关活性 小分子 |
依普利酮 | 艾沙利酮 | 醋酸氟氢可的松 | 坎利酮 | Osilodrostat | 阿帕利酮 | 地西利酮 |
密度 | 1.1±0.1 g/cm3 |
---|---|
沸点 | 504.1±50.0 °C at 760 mmHg |
熔点 | 157°C |
分子式 | C23H32O4 |
分子量 | 372.498 |
闪点 | 218.0±30.2 °C |
精确质量 | 372.230072 |
PSA | 60.44000 |
LogP | 4.53 |
外观性状 | 白色固体 |
蒸汽压 | 0.0±1.3 mmHg at 25°C |
折射率 | 1.542 |
储存条件 | Refrigerator |
水溶解性 | H2O: insoluble |
分子结构 |
1、 摩尔折射率:102.07 2、 摩尔体积(cm3/mol):324.2 3、 等张比容(90.2K):837.5 4、 表面张力(dyne/cm):44.5 5、 极化率(10-24cm3):40.46 |
计算化学 |
1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:0 3.氢键受体数量:4 4.可旋转化学键数量:4 5.互变异构体数量:15 6.拓扑分子极性表面积60.4 7.重原子数量:27 8.表面电荷:0 9.复杂度:707 10.同位素原子数量:0 11.确定原子立构中心数量:6 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
更多 |
1.性状:白色结晶性粉末,无臭、无味。在空气中稳定。乙醇溶液在240nm波长处有最大吸收。 2.熔点(℃):158-161。 3.比旋光度:[α]20D+168°-+176°(二氧六环)、+179°-+184°(1%,乙醇); 溶解度:4.本品溶于氯仿(1:1.5)、丙酮(1:30)、乙醇 (1:50),微溶于乙醚(1:170),几乎不溶于水。 |
醋酸去氧皮质酮毒性英文版
|
个人防护装备 |
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
安全声明 (欧洲) |
S22-S24/25 |
危险品运输编码 | UN 2811 |
WGK德国 | 3 |
RTECS号 | HG0525000 |
包装等级 | II |
危险类别 | 6.1 |
醋酸去氧皮质酮上游产品? 5 | |
---|---|
|
|
|
|
醋酸去氧皮质酮下游产品? 7 | |
|
|
|
黄体酮在四氢呋喃和甲醇混合溶液中与氧化钙和碘发生碘代反应,再与醋酸钾在无水丙酮中反应成酯,最后精制而得。
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicol. Mech. Methods 18 , 217-27, (2008)
ABSTRACT Drug-induced phospholipidosis (PL) is a condition characterized by the accumulation of phospholipids and drug in lysosomes, and is found in a variety of tissue types. PL is frequently manifes…
|
|
Antibacterial activity of enrofloxacin and ciprofloxacin derivatives of β-octaarginine. Chem. Biodivers. 12(2) , 179-93, (2015)
β(3) -Octaarginine chains were attached to the functional groups NH and CO2 H of the antibacterial fluoroquinolones ciprofloxacin (→1) and enrofloxacin (→2), respectively, in order to find out whether…
|
|
Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA-salt hypertension-induced vascular dementia in rats. Psychopharmacology 223(3) , 307-17, (2012)
Vascular dementia and hypertension are increasing day by day, with a high degree of co-occurrence. Tremendous amount of research work is required so that new pharmacological agents may be identified f…
|
|
21-Acetyloxypregn-4-ene-3,20-dione |
2-[(8S,9S,10R,13S,14S,17S)-10,13-Dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethylacetat |
DOXO |
Descotone |
Deoxycostone Acetate |
2-[(8S,9S,10R,13S,14S,17S)-10,13-Dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl acetate |
Pregn-4-ene-3,20-dione, 21- (acetyloxy)- |
3,20-Dioxopregn-4-en-21-ylacetat |
Desoxycorticosterone acetate (USP) |
Doca |
Syncort |
[2-[(8S,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate |
Acétate de 2-[(8S,9S,10R,13S,14S,17S)-10,13-diméthyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tétradécahydro-1H-cyclopenta[a]phénanthrén-17-yl]-2-oxoéthyle |
3,20-Dioxopregn-4-en-21-yl acetate |
MFCD00003660 |
EINECS 200-275-9 |
Pregn-4-ene-3,20-dione, 21-(acetyloxy)- |
Deoxycorticosterone acetate |